Enveric Biosciences, Inc.
- Home
- Companies
- Enveric Biosciences, Inc.
- Products
- Psybrary - Psychedelic Therapies
Psybrary - Psychedelic Therapies
Enveric Biosciences focuses on synthesizing novel, tailored and highly differentiated derivative molecules based on classic psychedelics such as psilocybin, N,N-dimethyltryptamine (DMT), mescaline and MDMA.
Most popular related searches
Enveric’s scientists synthesize newer versions of classic psychedelics using a mixture of chemistry and synthetic biology. Enveric adopted an agnostic approach to synthesis resulting in the creation of a proprietary library, the Psybrary™, which contains a larger and more diverse portfolio of molecular derivatives than what either discipline alone might achieve. To date, the Psybrary includes 15 patent families with over a million potential variations and hundreds of synthesized molecules.

